Quick Summary
The National Pharmaceutical Pricing Authority (NPPA) has notified the retail prices of 11 new drug formulations, acting under the powers granted by the Drugs (Prices Control) Order, 2013. The detailed order, published in the Gazette of India, specifies the retail prices (excluding GST) along with th
Daily Limit Reached
You have reached your daily limit of 2 Free News
Subscribe to CCI PRO for unlimited access
Why Upgrade to CCI PRO?
- No Ads
- WhatsApp Broadcasts
- Daily E-Newsletter
- Unlimited News Access
BEST VALUE
2 YEAR PLAN
3,499
(Inclusive of GST)
1 YEAR PLAN
1,999
(Inclusive of GST)
View all CCI PRO benfits
Already a PRO member? Login here for an ad-free experience.
FAQ :
The NPPA has notified the retail prices for 11 new drug formulations under the Drugs (Prices Control) Order, 2013.
The notification covers a range of drugs including cardiovascular, antibiotic, anti-allergic, anti-diabetic, and combination drugs.
Manufacturers may add GST only if it is actually payable to the government on the notified retail price, to avoid unjustified price inflation.
Manufacturers must issue a Form-V price list for all approved formulations from the date of notification and submit it to the NPPA, along with copies to State Drug Controllers and dealers.
If a manufacturer or marketer sells above the notified retail price, they will be required to deposit the overcharged amount with interest, and action will be taken under the DPCO 2013 and the Essential Commodities Act, 1955.
No, any previous price orders for these specific formulations, with the same strength and manufacturer/marketer, are superseded with immediate effect by this new notification.
CAclubindia
